LENZ Therapeutics (LENZ) Operating Leases (2021 - 2026)
LENZ Therapeutics (LENZ) posted quarterly Operating Leases of $673000.0 for Q1 2026, down 43.06% year-over-year from $1.2 million in Q1 2025, and up 92.29% quarter-over-quarter from $350000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Operating Leases (2021 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has reported Operating Leases for 6 consecutive years, with $673000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 43.06% year-over-year to $673000.0; the TTM figure through Mar 2026 stood at $673000.0 (down 43.06% YoY), while the FY2025 annual figure was $350000.0, down 57.0% from the prior year.
- Operating Leases rose to $673000.0 in Q1 2026 per LENZ's latest filing, from $350000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $50.6 million in Q2 2023 and bottomed at $156000.0 in Q1 2024.
- Historically, Operating Leases has averaged $7.1 million across 5 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2023 — Operating Leases jumped 1926.6% — and 2024, when it slumped 98.08%.
- LENZ Therapeutics' Operating Leases stood at $1.7 million in 2022, then slumped by 89.02% to $192000.0 in 2023, then soared by 323.96% to $814000.0 in 2024, then plunged by 57.0% to $350000.0 in 2025, then jumped by 92.29% to $673000.0 in 2026.
- Business Quant data shows LENZ's Operating Leases at $673000.0 in Q1 2026, $350000.0 in Q4 2025, and $954000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - |
| 10 | LENZ Therapeutics | 148.40 Mn | 148.40 Mn | 5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 569,000.00 |
| Mar 31, 2026 | 673,000.00 |
| Dec 31, 2025 | 350,000.00 |
| Sep 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 814,000.00 |
| Sep 30, 2024 | 953,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | 49.67 Mn |
| Jun 30, 2023 | 50.63 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 4.50 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Sep 30, 2021 | 4.68 Mn |